[Biological activity of regulatory peptides in model experiments in vitro].
Kozina. L S LS; Arutiunian. A V AV; Stvolinskiĭ. S L SL; Khavinson. V Kh VKh
Key Findings
- Vilon does not scavenge free radicals directly but can limit lipid peroxidation of human lipoproteins by altering their structure.
- The peptide improves the stability of red blood cell membranes against osmotic stress.
- It raises baseline intracellular reactive oxygen species yet reduces the proportion of dead neuronal cells, suggesting a role in regulating apoptosis or necrosis.
Practical Outcomes
- The data suggest vilon could be explored as a membrane‑protective supplement, potentially supporting blood and brain cell health. However, because the work is only in vitro and lacks dosage or safety information, biohackers should treat it as a preliminary clue rather than a ready‑to‑use protocol.
Summary
In lab tests, the short peptide vilon (along with pinealon, vesugen, and epitalon) didn’t act as a direct antioxidant, but it helped protect human lipoproteins from damage and made red blood cells tougher against swelling. It also raised steady levels of reactive oxygen inside cells while surprisingly keeping more nerve cells alive, hinting it might influence cell death pathways if taken in a living organism.
Abstract
Biological effects of short regulatory peptides, pinealon, vesugen, vilon and epitalon were studied in model experiments in vitro. These peptides were found not to demonstrate direct antioxidant activity but be able to restrict lipid peroxidation of human lipoproteins by modification of their structure. The short peptides increase stability of red blood cell membranes toward osmotic hemolysis. They also elevate the stationary level of intracellular reactive oxygen species and at the same time decrease (all excepting epitalon) percent of dead cells in neuronal population. The suggestion was made that under in vivo conditions, short peptides may participate in apoptosis/necrosis regulation.
Study Information
pubmed
2008